Sulphur Bentonite Market will reach valuation of US$ 164 Mn by 2018 and is expected to grow at CAGR ~ 5% for 2019–2029

Up from the global market value of US$ 164 Mn attained in 2018, sales of sulphur bentonite will observe promising growth during the forecast period, 2019 – 2029. A new market research report by Future Market Insights (FMI) on the sulphur bentonite market forecasts a promising growth outlook for the market during the decade-old period of projection. Demand from China would account for nearly 50% of total market value towards the end of 2029.

The report opines that market growth will be primarily driven by rapid growth in demand for increased crop yield. Application will be promising in oilseeds, fruits and vegetables, cereals, pulses, crops, lawns, turf, and trees.

Reduced Sulphur Deposition in Crops with Stringent Emission RegulationsGrowing emission regulations in EU countries have significantly reduced the sulphur deposition in crops below the standard requirements. Hence, there has been an increase in the need for more intense sulphur carriers such as sulphur bentonite.

According to the Sulphur Institute in the U.K., ~50% of the land area is sulphur deficient for winter wheat and rapeseed. Europe has also been a significant producer of oil seeds and the region has witnessed a significant increase in crop yield and cereals in France, Germany, and Spain. EU 28 are the largest producers of rapeseed, followed by Canada, China, India, and Australia.

The yield has increased by 10-20% for oilseeds, legume, cereals, and forage crops. Moreover, the increasing rape oilseed production for biofuel increases the demand for fertilizers.

SULPHUR BENTONITE MARKET STRUCTURE ANALYSIS

  • The global sulphur bentonite market has a fairly competitive landscape, where prominent market players are focusing on the development of joint ventures, concrete distribution partnerships, and targeting a stronger global footprint.
  • The sulphur bentonite market has been fairly moderate in size, which is the key factor for its dynamic competitive nature.
  • Prominent sulphur bentonite providers are presently prioritizing business expansion through merger and acquisition strategies with other repair and maintenance service providers in the market.
  • Extension of product portfolio is also identified to remain one of the key developmental strategies adopted by key players in the sulphur bentonite market.
  • Key market players are strategically focussing on strengthening their online portfolio in order to attract new customers and give a necessary boost to their revenue stream.
Demand Upsurge in Production of Oilseeds and CerealsSulphur bentonite market is expected to witness maximum revenue growth in the production of oilseeds, especially in Asia Pacific (APAC). On the other hand, sulphur bentonite is witnessing rapid traction in the production of cereals, pulses, and crops.

The study reveals that the application of sulphur bentonite in oilseeds and cereals will collectively account for the revenues exceeding US$ 100 Mn by 2029 end. Sales of Sulphur bentonite for pushing the yield of fruits & vegetables and lawn, turf, and trees will see modest growth throughout the projection period.

Key Takeaways – Sulphur Bentonite Market

  • Sulphur bentonite remains among the most intense sulphur carriers that helps in boosting crop yield and field productivity.
  • Sulphur bentonite is widely used as a fertilizer for numerous crops, cereals, vegetables such as oil seeds, rice, corn, onion, and citrus fruits.
  • Growing concerns regarding balanced plant nutrition and a significant increase in production and crop yield with the use of sulphur bentonite are projected to create traction in the market.
  • Asia Pacific (APAC) will hold a significant value share in global sulphur bentonite market, owing to the large agricultural base in the region.
  • China’s supremacy would further continue to solidify the position of APAC as an attractive market.
sulphur bentonite market share by region 2018 a

Oilseeds to Remain Key Application Area

Based on the market analysis by application, oilseeds are projected to hold significant value share in global sulphur bentonite market. The use of sulphur bentonite as a fertilizer for oilseeds such as rapeseed, soybean, groundnuts, and sunflower will see significant growth over the forecast period. This can be attributed to the increase in crop yield and oil content with the use of such fertilizers.

However, the cereals, pulses, and crops segment is estimated to experience lucrative growth opportunities in the market. The fruits and vegetables segment is estimated to grow at a high CAGR. The growing production of fruits and vegetables such as onion, garlic, ginger, and citrus fruits in the region is also projected to drive the market demand. Applications such as lawns, turfs, trees, and others are projected to remain niche application segments.

Sulphur Bentonite Market – Key Vendor Insights

The report presents some of the key market players, who are known as leaders in the global sulphur bentonite market. Some of the prominent players operating in the global sulphur bentonite market are Tiger-Sul Inc., National Fertilizer Limited, NEAIS, Coromandel International Limited, Sohar Sulphur L.L.C, Deepak Fertilizers and Petrochemicals, Coogee Chemicals Pty Ltd., H Sulphur Corp, Galaxy Sulfur, LLC, Montana Sulphur & Chemical Co., Zafaran Industrial Group Company, ABU DHABI FERTILIZER INDUSTRIES CO. W.L.L., and Devco Australia.

Sulphur Bentonite Market Taxonomy

The global sulphur bentonite market is segmented in detail to cover every aspect of the market and present complete market intelligence to the reader.

By Application

  • Oilseeds
  • Cereals, Pulses, and Crops
  • Fruits and Vegetables
  • Lawns, Turfs, Trees, and Others

By Region

  • North America
  • Latin America
  • Eastern Europe
  • Western Europe
  • Asia Pacific
  • Middle East and Africa

Botulism Market to Witness Excellent Revenue Growth, Overview, Emerging Trends and Forecast by 2026

Botulism is a rare but serious fatal paralytic disorder, caused by neurotoxins produced by a bacteria Clostridium botulinum. The symptoms of botulism are classified under foodborne botulism, wound botulism and infant botulism. some common symptoms include weakness, paralysis, vision, wallowing, breathing and speaking problems. The weakness further leads to fatigue of limb muscles. The symptoms are not caused by the bacterium itself, but by the toxin produced by the bacterium. Children with less than 6 months of age are primarily attacked by this bacteria and may also occur to children with poor immune system. The bacteria may enter the body through wounds, or by eating them from improperly canned or preserved food.

Patients who survive an episode of botulism poisoning may experience fatigue and shortness of breadth for years and long-term theray may be needed to aid recovery.

To remain ‘ahead’ of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-1480

Botulism Market: Drivers and Restraints

The major factors that drives growth of botulism market includes, increase in R&D practices, availability of efficient solutions for botulism, lack of hygienity in certain region of the world and increase in the awareness about disease and treatments. In addition, owing to strong efforts by WHO and CDC, the disease is getting irradiated slowly.However, high cost of R&D and government austerity are some of the hurdles expected to hinder the growth of botulism market.

Botulism Market: Overview

Botulism is generally treated with antitoxin and supportive care. Supportive care for botulism includes monitoring of respiratory function. Antitoxin is required in case of both foodborne and wound botulism. Wounds should be treated, usually surgically, to remove the source of the toxin-producing bacteria followd by administration of appropriate antibiotics. Mechanical ventilators are needed when there is a breathing problem while rehabilitation therapies are needed in case of speaking or swallowing problem. Health care providersmust tell state health authorities or the U.S. Centers for Disease Control and Prevention (CDC) about patients with botulism, so that the contaminated food can be removed from stores. Infants are more prone to unhygienic or contaminated food and hence, they are more prone to this disease.

Botulism Market: Region-wise Outlook

Region wise, the global botulism marketis classified into regions namely, North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa.The North American region is the most prominent market, followed by Europe. According to CDC, in the U.S., an average of 145 cases are reported each year. Of these, approximately 15% are foodborne, 65% are infant botulism and 20% are wound. However, Asia-Pacific region is the most promising market for the forecast period.

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-1480

Botulism Market: Key Players

The major players operating in botulism market includes XOMA Corporation, AlphaVax, Inc., Microbiotix, Inc., Molecular Targeting Technologies, Inc., and Morphotek, Inc. amongst others.

The report covers exhaustive analysis on:

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

Regional analysis includes

  • North America (U.S., Canada)
  • Latin America (Mexico, Brazil)
  • Western Europe (Germany, Italy, U.K, Spain, France, Nordic countries, BENELUX)
  • Eastern Europe (Russia, Poland, Rest Of Eastern Europe)
  • Asia Pacific Excluding Japan (China, India, ASEAN, Australia & New Zealand)
  • Japan
  • Middle East and Africa (GCC, S. Africa, N. Africa, Rest Of MEA)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Botulism Market: Segmentation

Botulism market can be segmented based on product type, distribution channel and geography.

Based on drug type, botulism market can be segmented as follows:

  • Antitoxin
  • Trivalent Antitoxin
  • Heptavalent Botulinium Antitoxin
  • Antibiotics

Based on distribution channel, botulism market can be segmented as follows:

  • Hospitals including hospital pharmacies
  • Clinics
  • Retail pharmacies

For critical insights, request for PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-1480

Report Highlights:

  • Detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint

Immunochemistry Analyzer Market Impacted by COVID-19, Market to Remain Dormant in Near Term, Projects FMI 2021-2025

Immunochemistry analyzer are becoming more and more popular in the global clinical chemistry and immunoassay as these are proved to be very effective tool to diagnose cancer, hepatitis, illegal drugs, fertility problems, sodium levels, endocrine function, and the detection of blood clots.

There are approximately more than 180,000 immunochemistry analyzers were installed globally in 2013. Out of which only about 17-20% of these analyzers are installed in the United States. This statistic suggests that the markets like China, India, and Japan where there is lack of basic lab facility prevails are adopting this new technology .Also it’s been seen that the recurring consumable sales are a strong factor to segment growth.

Immunochemistry analyzers are instruments that automatically run tests on samples from patients to detect any number of biologically active substances .It is very important to know which analyzer to use as different analyzers have different analysis time, and need different reagents which make these instrument highly sophisticated. These analyzers are mainly being used in infectious disease testing, cancer, cardiac, and autoimmune diseases.

To remain ‘ahead’ of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-866

Immunochemistry Analyzer Market: Drivers and Restraints

Under the strong rules & regulation laboratories find it difficult to have good revenues. Thus it’s very important to find ways to sustain in such a cost-crunched environment. Due to the cost cutting in clinical lab fees, profitability per test is decreasing which makes it necessary for the laboratories to focus on the volume rather than the value. There is also heavy pressure for quality, error-free results to ensure patient satisfaction. This forces labs to lean toward more automated systems with effective workflow solutions.

In US, Laboratories are encouraged for automation due to the heavy influx of patients with insurance coverage. But with limited workforce in the clinical lab it’s difficult to manage the huge inflow of patients. On the other hand patients need prompt & error free results. Thus this scenario demands laboratories to seek the help of systems that have a high accuracy, with managing high growing volumes and also offer remote data acquisition capabilities. The automated analyzers working with barcode readers, rack detection systems, and sample/plate identification modules to avoid plate or sample switch.

Immunochemistry Analyzer Market : Overview

With the rapid technological advancement in healthcare industry the immunochemistry analyzer market is expected to grow at a healthy CAGR in the forecasted period (2015-2025).

Globally, the immunochemistry market represents approximately 40.1% of the global in vitro diagnostics (IVD) market. Immunochemistry is by far the largest segment by volume, mostly due to routine testing. It is primarily driven by growing access to healthcare.

Immunochemistry Analyzer Market : Region-wise Outlook

Depending on geographic region, global immunochemistry analyzer market is segmented into seven key regions: North America, South America, Eastern Europe, Western Europe, Asia Pacific, Japan, and Middle East & Africa.

Demand for immunochemistry analyzers is slowing in the US and Western and Eastern Europe. Europe’s challenges in this segment include laboratory consolidation in France and economically troubled Greece, Italy, Spain, and Portugal. China’s growing rural hospital market lacks basic diagnostics laboratory infrastructure and represents an untapped opportunity for affordable immunochemistry analyzers.

Immunochemistry Analyzer Market : Key Players

The market is fully fragmented with leading brands, such as Siemens, Abbott Diagnostics, Beckman Coulter, Ortho Clinical Diagnostics, Thermo Fisher Scientific Inc.  and F. Hoffmann-La Roche Ltd.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, types, technology and applications.

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-866

The report covers exhaustive analysis on:

Market Segments

Market Dynamics

Market Size

Supply & Demand

Current Trends/Issues/Challenges

Competition & Companies involved

Technology

Value Chain

Regional analysis includes

North America (U.S., Canada)

Latin America (Brazil)

Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, Belgium, Netherlands, Luxembourg)

Eastern Europe (Poland, Russia)

Asia Pacific (China, India, ASEAN, Australia & New Zealand)

Japan

Middle East and Africa (GCC, S. Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Immunochemistry Analyzer Market:Segmentation

Immunochemistry analyzer market is segmented into following types:

Instruments

Reagents

Global immunochemistry analyzer Market, by Instrument Type

Instruments

Immunochemistry Analyzers

Chemiluminescence Immunoassay (CLIA) Analyzers

Immuno Fluorescence (IFA) Analyzers

Enzyme Immunoassay (EIA) Analyzers

Radioimmunoassay (RIA) Analyzers

Enzyme Linked Fluorescent Assay (ELFA) Systems

Multiplexed Assay Systems

Immunochemistry Stainers

Automated Stainers

Semi-Automated Stainers

Global Immunochemistry analyzer Market, By Application

Endocrinology

Oncology

Cardiology

Therapeutic Drug Development & Monitoring

Infectious Disease Testing

Drugs Of Abuse Testing

Others

For critical insights, request for PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-866

Report Highlights:

Detailed overview of parent market

Changing market dynamics in the industry

In-depth market segmentation

Historical, current and projected market size in terms of volume and value

Recent industry trends and developments

Competitive landscape

Strategies of key players and products offered

Potential and niche segments, geographical regions exhibiting promising growth

A neutral perspective on market performance

Must-have information for market players to sustain and enhance their market footprint

Surgical Navigation System Market 2021 Industry Research, Segmentation, Key Players Analysis and Forecast to 2025

Surgical Navigation Systems is one of the most reliable technology which is developed to render surgeries safer and less invasive as compared to the surgeries without Surgical Navigation Systems. Navigation during surgery is an excellent technology applied currently in medical devices. Surgical Navigation Systems have accelerated the technical processes in a surgery and paved the way for complex procedures. Surgical Navigation Systems target the anatomy to be operated on and guide to place the implant safely to the particular anatomy of the human body. Surgical Navigation Systems act as information centers during surgeries. Surgical Navigation System is essential in accurate visualization of the anatomy and in surgery planning in a virtual environment. Surgical Navigation Systems reduce risks associated with surgeries.

Surgical Navigation System Market: Drivers & Restraints

The global surgical navigation system market is driven by the navigation technology which encompasses surgical planning software, intra-operative imaging and instrument tracking technologies. Surgical Navigation Systems aid in guiding the surgeons to make data-oriented decisions during surgeries. This Surgical Navigation System technology is a driver for the global Surgical Navigation Systems market. A major factor that could adversely affect the growth of the global Surgical Navigation Systems market is the surge of minimally invasive and non-invasive surgeries. The minimally invasive and non-invasive surgeries are becoming popular among the masses owing to the rapid post-operative recovery with minimal pain to the patient.

To remain ‘ahead’ of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-977

Surgical Navigation System Market: Overview

Surgical Navigation System is also known as computer-aided surgery or computer-assisted intervention. The navigation system has to perform medical imaging of the anatomy which leads to image analysis. Based on the image generated, the navigation system helps in diagnosis and surgery simulation. The global surgical navigation system market is majorly dominated by the neurosurgery segment owing to the complicated procedures. Orthopedic navigation systems accounted for the second highest share in the global surgical navigation system market, closely followed by ENT navigation system.

Surgical Navigation System Market: Region-wise Outlook

Depending on geographic regions, global Surgical Navigation System market is segmented into seven key regions: North America, South America, Eastern Europe, Western Europe, Asia Pacific Excluding Japan, Japan, and Middle East & Africa. Due to the mature healthcare sector in the North American countries, North America held a substantial market share in the global surgical navigation system market and is expected to retain the share over the forecast period. The countries of Japan and Germany are projected to present considerable growth rate in the global surgical navigation system market due to the well-established infrastructure and advanced Information Technology (IT) in healthcare.

Surgical Navigation System Market: Key Players

Some of the key players in the global Surgical Navigation System are GE Healthcare Ltd., Medtronic Inc., Siemens Healthcare Corporation, Stryker Corporation, B.Braun Melsungen AG, Bausch & Lomb Incorporated, CAScination AG and Brainlab AG. The global surgical navigations system manufacturers are involved getting product approvals from Food and Drug Administration (FDA) and other regulatory authorities for market launch of their products. The global surgical navigations system market players are encouraging acquisitions and strategic collaborations to gain competitive advantage, expand into emerging markets and broaden the product portfolio.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, types, technology and applications.

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-977

The report covers exhaustive analysis on:

Market Segments

Market Dynamics

Market Size

Supply & Demand

Current Trends/Issues/Challenges

Competition & Companies involved

Technology

Value Chain

Regional analysis includes

North America (U.S., Canada)

Latin America (Mexico. Brazil)

Western Europe (Germany, Italy, France, U.K, Spain, Rest of Western Europe)

Eastern Europe (Russia)

Asia Pacific (China, India, ASEAN, Australia & New Zealand)

Japan

Middle East and Africa (GCC, S. Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Surgical Navigation System Market: Segmentation

Surgical Navigation System market is classified on the basis disease indication and geography.

Based on disease indication, the global Surgical Navigation System market is segmented into the following:

Neurosurgery Navigation System

Spine Navigation System

ENT Navigation System

Orthopedic Navigation System

For critical insights, request for PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-977

Report Highlights:

Detailed overview of parent market

Changing market dynamics in the industry

In-depth market segmentation

Historical, current and projected market size in terms of volume and value

Recent industry trends and developments

Competitive landscape

Strategies of key players and products offered

Potential and niche segments, geographical regions exhibiting promising growth

A neutral perspective on market performance

Must-have information for market players to sustain and enhance their market footprint

Dose Monitoring Devices Market 2021 Key Players, SWOT Analysis, Key Indicators and Forecast to 2025

Dose monitoring devices are devices which provides immediate enterprise-wide visibility into patient dose exposure for multiple modalities and PACS (Picture Archiving and Communication System). Dose monitoring devices are suitable for any size of healthcare facility, these devices provides patient radiation dose insights, monitoring and reporting with minimal staff involvement at a reasonable cost.

Dose monitoring devices provides the greatest access and flexibility in how you monitor, use and export dose data regardless of a hospitals size or configuration or number of modalities, units or even PACS system.

These devices enable the administration of reliable, automated radiation dose information and provide tools that support patient safety management and regulatory reporting requirements while improving quality assurance. These devices enables radiation dose tracking, dose analytics capabilities, dose reduction, and help in processing of better quality images.

To remain ‘ahead’ of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-736

Dose Monitoring Devices Market: Drivers and Restraints:

Presently, dose monitoring devices market is drive is by the technological advancement, increasing need for patient safety, compliance obligations of healthcare providers with stringent state and federal laws.

Dose monitoring device global market is driven by the technological advancement, rapid innovation in production and modeling technologies, increasing computed tomography procedures performed around the globe, increase in adoption of electronic health records (EHRs), and increasing awareness and knowledge among patients regarding the consequences of prolonged or extended radiation exposure. However, lack of funding, ignorance towards radiation dose management by healthcare professionals, and lack of set skilled professionals act as major barrier for this market around the globe.

Dose Monitoring Devices Market: Overview:

With rapid technological advancement,increasing need for patient safety and increasing awareness and knowledge among patients regarding the consequences of prolonged or extended radiation exposure the dose monitoring devices global market is expected to have a healthy growth rate in the forecast period (2015-2025).

Dose Monitoring Devices Market: Region-wise Outlook:

Depending on geographic regions, global dose monitoring devices market is segmented into seven key regions: North America, South America, Eastern Europe, Western Europe, Asia Pacific, Japan, and Middle East & Africa.

Geographically, North America dominates the market primarily due to strict regulations for patient safety and patient care. Factors like increasing risks and incidences of chronic disorders and increasing measures for patient safety are driving the growth of this market in this region.

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-736

Dose Monitoring Devices Market: Key players:

Some of the key participating global players of this market are GE healthcare (U.K), Siemens Healthcare (Germany), Sectra Medical systems (Sweden), Philips N.V (Netherlands), Bayer AG (Germany) and others, IBA Dosimetry GmbH and Mirion Technologies, Inc.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, types, technology and applications.

The report covers exhaustive analysis on:

Market Segments

Market Dynamics

Market Size

Supply & Demand

Current Trends/Issues/Challenges

Competition & Companies involved

Technology

Value Chain

Regional analysis includes:

North America (U.S., Canada)

Latin America (Mexico. Brazil)

Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, Belgium, Netherlands, Luxembourg)

Eastern Europe (Poland, Russia)

Asia Pacific (China, India, Australia & New Zealand)

Japan

Middle East and Africa (S. Africa, N. Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Dose Monitoring Devices Market: Segmentation:

Dose monitoring devices market is segmented into following types:

On the basis of product:

Medical Radiation Dosimeters

Radiation Survey Meters

Dose Monitoring Software

Service

On the basis of application:

Radiography

Computed Radiography

Mammography

Fluoroscopy and Interventional Imaging

Others (Nuclear Medicine)

For critical insights, request for PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-736

Report Highlights:

Detailed overview of parent market

Changing market dynamics in the industry

In-depth market segmentation

Historical, current and projected market size in terms of volume and value

Recent industry trends and developments

Competitive landscape

Strategies of key players and products offered

Potential and niche segments, geographical regions exhibiting promising growth

A neutral perspective on market performance

Must-have information for market players to sustain and enhance their market footprint

Virtual Companion Care Market 2021| Scope of Current and Future Industry 2027

In the age of digitization, relationship between patients and care-givers or health maintenance organizations is changing rapidly as various technologies are being employed by primary and secondary users of health care services across the globe. The popularity of virtual worlds is increasing over the time and healthcare systems are thus using it for promoting healthy behavior. Virtual companion care represents an example of virtual reality that represents a virtual agent which is incorporated with an artificial conversational entity like cathbot, and can display appropriate non-verbal behavior after communicating with existing healthcare databases. Elder population can talk to them in a normal conversational tone and the virtual agent can speak back, answer questions, read news for them, etc. Many elderly people living alone at home require companionship. There are different technologies such as mobile phones and computers that can connect these elderly patients to their families however these technologies can provide only companionship as much as busy family members can do. Virtual companion care provides alternative that can be a substitute for in-person human contact and alleviate loneliness. The concept of virtual caregiving however cannot replace the human companionship although it can be viewed as a way to decrease the time for companion sessions and thus is cost saving. The cost of virtual companion care services in the U.S. is approximately US$ 200 per month. Virtual companion care services have made caring for seniors very easy and feasible.

Virtual Companion Care Market: Drivers and Restraints

Primary factors driving growth of virtual companion care market are rapidly growing geriatric population, technological advancements, penetration of technology among general population and elderly population and need for companion care services due to elder population living alone at the home. According to U.S. Department of Health and Human Services and the National Ambulatory Medical Care survey, population aged over 65 in the U.S. will be doubled by 2030. Majority of elderly people may not need assistance but require companionship and thus virtual companion care is adopted by them. Even though information society is gaining importance over time elderly people are major challenge in this respect as they lack interest and knowledge of technological progress. This is expected to limit the growth of virtual companion care market.

To remain ‘ahead’ of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-5526

Virtual Companion Care Market: Overview

Market for virtual companion care is in early stage of development and majority of population in developing countries is yet to know about it. Majority of the platforms are being developed by the universities and are expected to be completed and launched over the forecast period of 2017–2027. Even in developed countries such as the U.S. and European countries the concept of virtual companionship is not readily adopted by the general population. Under its Eurostatrs Program, European Union is developing Naviga platform which allows elder people and persons with disability to access the internet and the information society. The platform also provides home rehabilitation physiotherapy through virtual reality applications.

Virtual Companion Care Market: Regional Outlook

Geographically, global virtual companion care market is classified into regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa. North America clearly dominates the global virtual companion care market due to high penetration of technology and internet among elderly population. Europe is expected to be the second largest market due to government initiatives for providing companion care to elderly. Japan virtual companion care market is expected to witness robust growth due to number of companies working to develop virtual platforms for elderly care.

Virtual Companion Care Market: Key Players

Some of the players identified in global virtual companion care market include Claris Healthcare Inc., General Electric Company, AIST Japan, GeriJoy Limited, Living Assistance Services Inc. etc.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.

The report covers exhaust analysis on:

Market Segments

Market Dynamics

Market Size

Supply & Demand

Current Trends/Issues/Challenges

Competition & Companies involved

Technology

Value Chain

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-5526

Regional analysis includes:

North America (U.S., Canada)

Latin America (Mexico. Brazil)

Western Europe (Germany, Italy, France, U.K, Spain)

Eastern Europe (Poland, Russia)

Asia Pacific (China, India, ASEAN, Australia & New Zealand)

Japan

Middle East and Africa (GCC Countries, S. Africa, Northern Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macroeconomic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Virtual Companion Care Market: Segmentation

Tentatively, global virtual companion care market has been segmented on the basis of end user, and geography

Based on end user, global virtual companion care market is segmented as below:

Long-term Care Centers

Home Care Settings

Rehabilitation Centers

Old Age Homes

For critical insights, request for PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-5526

Report Highlights:

Detailed overview of parent market

Changing market dynamics in the industry

In-depth market segmentation

Historical, current and projected market size in terms of volume and value

Recent industry trends and developments

Competitive landscape

Strategies of key players and products offered

Potential and niche segments, geographical regions exhibiting promising growth

A neutral perspective on market performance

Generic Oncology Drugs Market Is Poised To Surpass A Striking CAGR Of 6% Through 2028

Generic oncology drugs, being able to detect and treat tumors, are utilized extensively in the healthcare industry for treating cancer. Notable enhancements in the technology with the blend of information is expected to accelerate the pace of growth for the generic oncology drugs market and the cost pertaining to the treatment of cancer. Advanced technologies such as real world data, mobile apps, and artificial intelligence have successfully been able to achieve a high engagement rate of the patients, which has resulted in increasing awareness of the cancer treatment among the patients.

A significant increase has been noted in the spending capacity for the development of cancer. More than one-third of the trials proposed by the manufacturers are aimed at offering personalized cancer treatments, which further propels the demand for generic oncology drugs. A host of these factors have contributed massively to the expansion of the generic oncology drugs market at the global level.

According to a report, the global generic oncology drugs market is poised to surpass a striking CAGR of 6% through 2028. Increasing inclination of individuals towards smoking and tobacco consumption is the chief cause of cancer. Secondary factors such as sedentary lifestyle, genetic causes, viral infections, carcinogens, and high consumption of junk food make the human body susceptible to cancer. Growing concerns of a high number of deaths occurring on the back of cancer have provoked the government authorities to take effective steps for preventing cancer.

Increasing incidences of cancer have been detected, ascending from the proclivity for cigarettes and tobacco among individuals. The number of cancer-infected patients is stimulated by viral infections, carcinogens, lack of physical activities, genetic causes, age, and unhealthy eating habits. Recent developments in the healthcare sector have broadened the scope of therapies for the treatment of cancer by leveraging oncology.

To remain ‘ahead’ of your competitors, request for a sample

Notable Developments in the Generic Oncology Drugs Market

Improvement in cancer treatment drugs and therapies have been one of the most underlying aims of the pharmaceuticals and medical organizations operating at the global level. Consequently, generic oncology drugs have been utilized for innovating novel therapies and increasing the survival rates of patients.

Blood Cancer Immensely Contributes to the Growth of the Generic Oncology Drugs Market

Amongst the various types of cancer such as skin cancer, bladder cancer, bone cancer, eye cancer, gastrointestinal cancer, gynecological cancer, lung cancer, endocrine cancer, and blood cancer is accounted for generating the largest share for the generic oncology drugs market. Patients diagnosed with blood cancer seek complete treatment to this chronic disease, as a result of which excessive demand for generic oncology drugs is created. In addition to this, the high cost of the therapies and generic oncology drugs play a crucial role in the growing size of the generic oncology drugs market.

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-8961

Recent Developments to Drive the Growth of the Generic Oncology Drugs Market

The key players involved in transforming the landscape of the generic oncology drugs market include

  • Bayer Healthcare AG
  • Amgen
  • Teva Pharmaceutical Industries
  • Pfizer
  • Boehringer Ingelheim GmbH
  • AstraZeneca
  • Hoffmann-La Roche Ltd.
  • Eli Lily and Company
  • ARIAD Pharmaceuticals Inc.
  • GlaxoSmithKline
  • CELGENE Corporation
  • Novartis AG
  • Johnson and Johnson
  • AbbVie Inc.
  • Merck & Co.
  • Sanofi

For critical insights, request for PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-8961

Out of these leading players, CELGENE, Novartis, and Roche have been procuring a considerable share in the generic oncology drugs market with a rich product portfolio and pipeline products aimed at treating cancer effectively.

Novartis AG applied smart strategies for channel integration like eCommerce with mobile application to fuel the sales at the retail stores. In addition to this, the company achieved a CE mark for its gene modifying therapy used for the treatment of blood cancer.

Pfizer Inc. has been focusing on the over 39 therapies, in order to fortify its product portfolio. In the year 2017, Glasdegib of Pfizer received the priority review from the U.S. FDA to treat myeloid leukemia. Post this, XTANDI of Pfizer as well received the FDA approval.

Many similar key development shaping the landscape of the existing generic oncology drugs market have been incorporated in the report.

Antibiotic Susceptibility Testing Market Is Anticipated To Expand At A CAGR Of 5.6% Over The Forecast Period 2021–2028

Growing use of antibiotics in treating even the most common health conditions remains a strong factor boosting demand for antibiotic susceptibility testing (AST). Increasing government funds for microbial and antibiotic susceptibility testing research and consistently improving outcome of PPPs in terms of enhanced screening and evaluation of antibiotics are playing a pivotal role in strengthening the performance of antibiotic susceptibility testing market. CDC’s ‘AMR Challenge’ involving bioMérieux is a recently announced as objective to accelerate research efforts in the field of microbial resistance.

A recently published research intelligence on the global antibiotic susceptibility testing market by Future Market Insights tracks the top five influencers pushing demand and revenue growth of the market at a global level.

  • Infectious diseases, prevailing at a high pace
  • Increasing rate and tenure of hospitalization
  • Growing significance of early diagnostics
  • Soaring research interests in microbial susceptibility testing
  • Improving funding scenario for research, driven by governments & private bodies

Towards 2019, global revenue through total installed base of antibiotic susceptibility testing systems is likely to see 6.4% yearly growth over that achieved in 2018.

To remain ‘ahead’ of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-8574

Prominent Players:

  • BD
  • Danaher
  • Thermo Fischer Scientific
  • Bio-Rad Laboratories
  • Creative Diagnostics
  • Accelerate Diagnostics
  • Alifax
  • Liofilchem srl
  • bioMérieux SA
  • Merck KgaA

Entry of Technologically Advanced AST Systems to Favor Market Growth

As indicated by research, the sales of antibiotic susceptibility testing equipment will witness healthy growth owing to increasing demand for specific susceptibility testing systems to define the scope of targeted therapy. Targeting key pathogens is imperative to design a highly specific plan of treatment for a particular patient, and antibiotic susceptibility testing systems efficiently allow researchers to achieve it within a significantly short timeline.

With FDA approving a considerable number of antibiotic and microbial susceptibility testing equipment, especially in the recent past, FMI forecasts an impressive installed base for antibiotic susceptibility testing systems in coming years. Advanced technology enabled antibiotic susceptibility testing equipment allows early diagnosis that in turn improves chances of developing targeted therapy earlier. One such recent advancement enjoying visibly growing traction in market includes oCelloScope. This antibiotic susceptibility testing equipment by BioSense Solutions is an optical susceptibility screening system with the capability to deliver real-time, time-lapse imaging of multiple microbial combinations, simultaneously.

Recently, Thermo Fisher Scientific, Inc. and Becton, Dickinson and Company received FDA approvals for their new launches in antibiotic susceptibility testing space. Moreover, FDA passed an approval to a susceptibility testing device by bioMérieux that has an expanded capability to identify a particular pathogen.

Research in Screening of High Pathogen Concentration Samples to Propel Demand for AST

The process of spotting a specific set of genes responsible for antibiotic resistance is highly complicated when it comes to handling the complexities associated with samples that have high concentration of pathogens. Some of the highly desirable antibiotic susceptibility testing systems that allow direct-from-sample pathogen identification through high pathogen concentration samples, are thus likely to gain high traction in coming years.

Growing research efforts in the recognition of the presence of a specific set of antibiotic resistant genes can direct efforts for identification and selection of narrow-spectrum antibiotics, which remains among the most prominent factors pushing installed base of such antibiotic susceptibility testing equipment.

A few recent launches in this segment include

  • Genmark Diagnostics
  • ePLEX Blood Culture ID Panel
  • Biomerieux’s BioFire FilmArray
  • Luminex Corp.’s Verigene Bloodstream Infection Panel.

The report also sheds light on the increasing role of Ecommerce in the market by boosting the availability of antibiotic susceptibility testing systems. Offering improved access to susceptibility testing devices by industry’s leading brands, online retail operators have been attracting prominent vendors in the global antibiotic susceptibility testing market. A number of vendors dealing in antibiotic susceptibility testing equipment are opting for devices that are available online owing to the significantly reduced costs and additional discounts on price.

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-8574

Additional Questions Answered

Some of the additional questions addressed in this report on the antibiotic susceptibility testing market-

  • What is the revenue potential of the antibiotic susceptibility testing market across regions of North America and Europe?
  • Who are the key competitors and what are their portfolios in the antibiotic susceptibility testing market?
  • What are the major challenges influencing the growth of the antibiotic susceptibility testing market?
  • How intervention from regulatory authorities is shaping the antibiotic susceptibility testing market growth?

Key Segment

Based on product type

  • instruments
    • automated broth microdilution systems
    • manual broth microdilution systems
    • semi-automated broth microdilution systems
  • software & services
    • image & analysis software
    • installation services
  • kits & reagents

Based on applications

  • sepsis
  • respiratory infections
  • gastrointestinal infections
  • meningitis & encephalitis
  • endocarditis
  • others

For critical insights, request for PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-8574

Based on end user

  • diagnostic laboratories
  • hospitals
  • research laboratories

Based on regions

  • North America
  • Latin America
  • Europe
  • Asia-Pacific
  • Middle East & Africa

Cellulite Treatment Market to Reach US$ 2,100 Million, Globally, by 2027 at 8.1% CAGR: FMI

Hard Cellulite Predicted to Hold an Attractive Market Share in the Near Future

One major driver behind the growth of cellulite treatment market is the increasing number of obese population. There are also increased number of cases for fat deposition. The people who are comparatively overweight mostly face this problem, in turn triggering the demand for cellulite treatment. These cases have helped people grow aware about cosmetic surgeries and has also broadened the scope of these surgeries in market. There’s a significant rise in aesthetic procedures taking place worldwide. Especially in Brazil, where there were around 5,500 cosmetic surgeons performing the second highest number of aesthetic procedures after the U.S. Around 1,450,020 minimally invasive and non-surgical procedures were performed in Brazil in 2016. Among different types of cellulite, hard cellulite is expected to register a growth rate of around 7.8% during 2018-2028, which is higher than other cellulite types.

Cellulite is a health condition which is more prevalent in women. With the growing health related complexities witnessed in women, there’s also a growth in rate of people suffering from cellulite. A new research report by Future Market Insights revolves around examining the current scenario of global cellulite treatment market as well as forecast for its upcoming years. This comprehensive research report is titled ‘Cellulite Treatment Market: Global Industry Analysis 2013 – 2017 and Opportunity Assessment 2018 – 2028’.

To remain ‘ahead’ of your competitors, request for a sample

North America Slated for Strongest Projections in the Global Cellulite Treatment Market

Among the major regional divisions made for the research conducted on global cellulite treatment market, North America shows the strongest prospects with an expected market value of over US$ 2,100 Mn by the end of 2028, growing at an impressive CAGR of 8.1% during the forecast period. The growth is helped by North America’s moderate economy and healthcare market. Also, in the U.S., a large base of population, especially youngsters, suffer from fat deposition related disorders. The region is also ahead of other regions due to its developed economy and advanced facilities. The cellulite treatment involves advanced techniques which are also costly for people to afford. This makes the market more prominent in developed regions like North America.

Global Cellulite Treatment Market: Competitive Landscape

The research report has a detailed scenario of competition going on in the global cellulite treatment market. It includes a SWOT analysis of big companies that are vigorously involved providing cellulite treatments to people.

  • Merz Pharma GmbH & Co.
  • KGaA,
  • Cynosure, Inc. (Sub. Hologic Inc.),
  • Tanceuticals,
  • LLC.,
  • Inceler Medikal Co. Ltd.,
  • Cymedics,
  • Nubway,
  • Zimmer Aesthetics,
  • Syneron Medical Inc

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-3560

Market Taxonomy

Treatment Procedure

  • Non-Invasive
  • Minimally Invasive
  • Topical Treatment

Cellulite

  • Soft Cellulite
  • Hard Cellulite
  • Edematous Cellulite

End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialized Dermatology Clinics

For critical insights, request for PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-3560

Region

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • Asia-Pacific excluding Japan
  • China
  • Japan
  • Middle East & Africa

Exosome Diagnostic and Therapeutics Market is projected to expand at a high CAGR of 23.1% during the period of assessment

Future Market Insights in its recent research report titled “Exosome Diagnostic and Therapeutics Market: Global Industry Analysis (2012-2016) and Opportunity Assessment (2017-2027)” covers several factors that are influencing the robust growth of the global market. As per this research report, the global exosome diagnostic and therapeutic market is projected to expand at a high CAGR of 23.1% during the period of assessment. The exhaustive research publication includes key trends, opportunities, threats, growth drivers and challenges that impact the global exosome diagnostic and therapeutics market. Detailed pricing analysis of different exosome diagnostic and therapeutics across key regions is also discussed in the research study. The segmental analysis across North America, Western Europe, Eastern Europe, Asia Pacific excluding Japan (APEJ), Latin America, Japan and Middle East and Africa (MEA) is carried out which is used to track the future projections for a period of ten years, pertaining to value, of the global exosome diagnostic and therapeutics market.

To remain ‘ahead’ of your competitors, request for a sample

Segmentation Highlights of the Global Exosome Diagnostic and Therapeutics Market

The global exosome diagnostic and therapeutics market is segmented on the basis of product type, application, end user and region.

In the region category, North America is estimated to be the largest with a high market lucrativeness. This region is expected to grow at a significant CAGR during the forecast period to touch a large market estimation by end of the assessment year, thus leading the global market. Moreover, Asia Pacific excluding Japan (APEJ) is the fastest growing region and is the second largest in terms of adoption and use of exosome diagnostics and therapeutics. APEJ is filled with high growth opportunities and is being targeted by several giants in this sector, such as Thermo Fisher Scientific.

Global Market for Exosome Diagnostic and Therapeutics: Underlying Forces Influencing Growth

The growth of global market for exosome diagnostics and therapeutics is influenced by several factors. Increasing need for screening and diagnosis of chronic diseases coupled with high therapeutic potential of exosomes are fuelling the adoption of exosome diagnostics and therapeutics. Moreover, introduction of explicit systems for analysis of proteins specific to exosomes, increasing research and development activities supported by favourable government policies across various regions and increasing popularity of exosome over CTC and ctDNA are expected to trigger the growth of the global market for exosome diagnostic and therapeutics market in the years to follow. On the contrary, lack of standardization and validation requirements for isolation of exosomes is expected to pose hindrances to the growth of the global market. Other factors negatively impacting the market’s growth include heavy investments in research and development and insufficient insurance coverage of costly cancer diagnostic tests.

By product type, reagents and kits are gaining high traction owing to increasing use in exosome diagnostics and therapeutics. The reagents and kits segment dominated the market in 2017 and is anticipated to continue with the trend in the coming years. This segment is also expected to expand at a high growth rate during the forecast period. The reagents and kits segment is expected to register a high CAGR of 28.2% throughout the period of forecast. The software segment is the second fastest growing segment spurring the growth of the global market.

In the application category, diagnostic segment is the largest as compared to therapeutics segment and is estimated to touch a value of over US$ 90 Mn by the end of the year of assessment, growing at a significant pace. Therapeutics segment is projected to expand at a CAGR of 29.0% throughout the period of assessment.

With respect to end user, the use of exosome diagnostic and therapeutics is largely observed in diagnostic centres. The diagnostic centres segment is expected to surpass other end user segments with a high market share and growth rate in the coming years.

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-6379

Forecast Analysis of the Global Exosome Diagnostic and Therapeutics Market

According to the research report, the global market for exosome diagnostic and therapeutics is expected to grow at a high CAGR to reach an estimate of over US$ 150 Mn by the end of the year of assessment from a value of about US$ 19 Mn in 2017.

Competitive Landscape Shaping the Global Exosome Diagnostic and Therapeutics Market

Manufacturers of exosome diagnostic and therapeutics are focusing to raise capital required for launch of new products or research and development expenses through venture financing. Key companies such as

  • Thermo Fisher Scientific Inc.
  • NanoSomix Inc.
  • NX PHARMAGEN
  • Capricor Therapeutics Inc.
  • Exosome Diagnostics Inc.
  • Exiqon A/S (Aethlon Medical Inc.).
  • System Biosciences Inc.
  • Aegle Therapeutics AMS Biotechnology (Europe) Limited
  • Miltenyi Biotec.

Market segmentation

By Product Type

    • Instrument
  • Software
  • Reagents and Kits

By Application

  • Diagnostics
  • Therapeutics

By End User

  • Hospitals
  • Cancer Institutes
  • Diagnostic Centres
  • Others

By Region

  • North America
  • Latin America
  • Eastern Europe
  • Western Europe
  • Asia Pacific excluding Japan
  • Japan
  • Middle East and Africa

For critical insights, request for PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-6379